FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4539711000001106: Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17856101000001111 Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17856201000001116 Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Is a Generic Pyrogastrone oral suspension true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has active ingredient Carbenoxolone sodium false Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has active ingredient Aluminium hydroxide dried false Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has active ingredient Potassium bicarbonate false Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has active ingredient Potassium bicarbonate false Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Is a Pyrogastrone true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has specific active ingredient Carbenoxolone sodium true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has specific active ingredient Aluminium hydroxide dried true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has specific active ingredient Potassium bicarbonate true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has active ingredient Aluminium hydroxide true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has active ingredient Magnesium trisilicate true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has active ingredient Carbenoxolone true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has active ingredient Sodium bicarbonate true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has active ingredient Alginic acid true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) 500 ml Is pack of False Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier
Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) 500 ml Has AMP True Pyrogastrone oral suspension (Sanofi-Synthelabo Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start